Insecticides (India) quarterly results

Q1 FY27 · Apr–Jun 2026

₹ crore	Q1 FY27	Q1 FY26	Change
Revenue	612	691	−11.5%
EBITDA	67.6	84.6	−20.1%
EBITDA margin	11.1%	12.2%	−1.2 pts
Profit before tax	58.5	77.3	−24.2%
Net profit	43.9	58.1	−24.5%
EPS	₹15.08	₹19.97	−24.5%

Every quarter

₹ crore except per share

Tap a line for its trend	Q1 FY27Jun 2026	Q4 FY26Mar 2026	Q3 FY26Dec 2025	Q2 FY26Sep 2025	Q1 FY26Jun 2025	Q4 FY25Mar 2025	Q3 FY25Dec 2024	Q2 FY25Sep 2024	Q1 FY25Jun 2024	Q4 FY24Mar 2024	Q3 FY24Dec 2023	Q2 FY24Sep 2023	Earlier quartersAlpha Plus

Expenses
	612	426	385	638	691	359	358	627	657	273	358	696	Earlier quartersEvery year the company has filed comes with Alpha Plus.
	5.3	4.7	0.8	2.5	3.7	2.9	0.2	1.5	2.5	4.5	1.2	−0.2
	617	431	386	640	695	362	358	629	659	277	359	696
	358	247	218	363	373	326	236	449	339	270	260	392
	107	51.6	15.1	57.8	45.1	12.2	21.0	21.0	21.0	7.7	39.4	67.5
	−46.9	−0.8	27.4	−2.9	71.5	−111	−28.4	−41.4	116	−92.2	−49.8	63.3
	47.3	38.0	36.5	47.8	41.5	28.6	32.5	38.5	38.8	25.8	27.7	34.1
	4.7	4.3	4.7	4.2	3.7	2.1	1.4	1.7	1.6	2.1	2.8	2.9
	9.7	9.4	9.4	9.3	7.3	7.2	7.6	7.2	7.1	7.6	7.4	7.4
	78.2	65.3	61.0	82.5	75.5	74.2	65.8	70.4	70.2	52.1	54.2	57.5
	558	414	372	562	618	340	336	546	594	273	342	624
	67.6	25.6	27.4	89.5	84.6	28.5	30.9	89.6	71.5	9.0	26.0	81.9
	57.9	16.2	18.0	80.1	77.3	21.3	23.3	82.3	64.4	1.4	18.6	74.6
Profit
	58.5	16.6	14.1	78.5	77.3	22.0	22.1	82.1	65.3	3.8	17.0	71.5
	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0
	58.5	16.6	14.1	78.5	77.3	22.0	22.3	82.1	65.3	3.8	17.0	71.5
	16.5	1.0	4.3	19.8	18.7	12.3	5.4	20.9	17.2	−1.5	5.4	18.3
	−1.6	3.3	−0.5	−0.1	0.6	−4.1	−0.5	−0.0	−0.8	−2.5	−0.7	0.3
	14.9	4.4	3.8	19.7	19.3	8.1	4.9	20.8	16.4	−4.0	4.8	18.6
	0.3	−0.5	0.2	0.4	0.2	0.0	0.0	0.2	0.2	−0.1	0.0	0.2
	43.9	11.7	10.5	59.1	58.1	13.9	17.4	61.5	49.0	7.8	12.3	53.2
	43.6	12.2	10.2	58.8	57.9	13.9	17.4	61.3	48.8	7.8	12.3	53.0
	−1.6	2.4	−1.5	1.4	−0.1	−0.7	−0.7	1.9	−1.7	1.4	0.1	−1.2
	42.3	14.1	9.0	60.5	58.1	13.1	16.6	63.3	47.3	9.1	12.4	51.9
	43.9	11.7	10.5	59.1	58.1	—	—	61.5	49.0	7.8	12.3	—
	0.0	2.4	0.0	0.0	0.0	0.0	—	0.0	0.0	0.0	0.0	—
Per share
	₹15.08	₹4.02	₹3.60	₹20.31	₹19.97	₹4.77	₹5.96	₹20.78	₹16.56	₹2.62	₹4.16	₹17.95
	₹15.08	₹4.02	₹3.60	₹20.31	₹19.97	₹4.77	₹5.96	₹20.78	₹16.56	₹2.62	₹4.16	₹17.95
Other comprehensive income — detail
	−1.6	2.4	−1.5	1.4	−0.1	−0.7	—	—	—	—	—	—
	−2.1	2.4	−1.5	1.4	−0.1	−0.7	−0.7	1.8	−1.7	1.4	0.1	−1.2
	−0.5	0.0	0.0	0.0	0.0	0.0	—	—	—	—	—	—
	—	—	0.0	0.0	−0.0	0.0	−0.0	0.0	−0.0	—	—	—
	42.3	14.1	9.0	—	58.1	—	16.6	—	—	—	12.3	—
Per share — as-filed variants
	₹15.08	₹4.02	₹3.60	₹20.31	₹19.97	₹4.77	₹5.96	₹20.78	₹16.56	₹2.62	₹4.16	₹17.95
	₹15.08	₹4.02	₹3.60	₹20.31	₹19.97	₹4.77	₹5.96	₹20.78	₹16.56	₹2.62	₹4.16	₹17.95
Derived — gross profit (revenue − materials − purchases − Δ inventories)
	193	129	125	220	202	131	129	198	181	86.9	108	174
	31.6%	30.2%	32.4%	34.5%	29.2%	36.6%	36.1%	31.6%	27.5%	31.9%	30.2%	24.9%
Adjusted (ex-exceptional items) — derived
	58.5	16.6	14.1	78.5	77.3	22.0	22.1	82.1	65.3	3.8	17.0	71.5
	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0
	43.9	11.7	10.5	59.1	58.1	13.9	17.2	61.5	49.0	7.8	12.3	53.2
	₹15.08	₹4.02	₹3.60	₹20.31	₹19.97	₹4.77	₹5.90	₹20.78	₹16.56	₹2.62	₹4.16	₹17.95

Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

alphave

INSECTICID₹517.80

Insecticides (India) Limited

· Chemicals

Annual Quarterly₹ CrorePeersIPL MOL BHARATRAS PUNJABCHEM ASTEC GSPCROP DHARMAJ BHAGCHEMMcap ₹1,507 Cr

View

In ₹ Crore except Per Share 3 Months Ending	Q2 FY24 30/09/2023	Q3 FY24 31/12/2023	Q4 FY24 31/03/2024	Q1 FY25 30/06/2024	Q2 FY25 30/09/2024	Q3 FY25 31/12/2024	Q4 FY25 31/03/2025	Q1 FY26 30/06/2025	Q2 FY26 30/09/2025	Q3 FY26 31/12/2025	Q4 FY26 31/03/2026	Q1 FY27 30/06/2026
Revenue from Operations	696.0	357.9	272.5	656.7	627.1	357.7	358.9	691.1	637.7	384.9	426.3	611.5
Other Income	-0.2	1.2	4.5	2.5	1.5	0.2	2.9	3.7	2.5	0.8	4.7	5.3
Total Income	695.8	359.2	277.0	659.2	628.6	357.9	361.8	694.8	640.2	385.7	431.0	616.9
Expenses
+ Cost of Materials Consumed	391.7	260.4	270.1	339.1	449.1	236.0	326.4	372.9	363.0	217.6	246.7	358.3
+ Purchases of Stock-in-Trade	67.5	39.4	7.7	21.0	21.0	21.0	12.2	45.1	57.8	15.1	51.6	107.0
+ Changes in Inventories	63.3	-49.8	-92.2	116.0	-41.4	-28.4	-111.0	71.5	-2.9	27.4	-0.8	-46.9
+ Employee Benefit Expense	34.1	27.7	25.8	38.8	38.5	32.5	28.6	41.5	47.8	36.5	38.0	47.3
+ Finance Costs	2.9	2.8	2.1	1.6	1.7	1.4	2.1	3.7	4.2	4.7	4.3	4.7
+ Depreciation & Amortisation	7.4	7.4	7.6	7.1	7.2	7.6	7.2	7.3	9.3	9.4	9.4	9.7
+ Other Expenses	57.5	54.2	52.1	70.2	70.4	65.8	74.2	75.5	82.5	61.0	65.3	78.2
Total Expenses	624.3	342.1	273.2	593.9	546.5	335.8	339.8	617.6	561.7	371.6	414.4	558.3
EBITDA	81.9	26.0	9.0	71.5	89.6	30.9	28.5	84.6	89.5	27.4	25.6	67.6
EBIT	74.6	18.6	1.4	64.4	82.3	23.3	21.3	77.3	80.1	18.0	16.2	57.9
Profit
PBT before Exceptional Items	71.5	17.0	3.8	65.3	82.1	22.1	22.0	77.3	78.5	14.1	16.6	58.5
+ Exceptional Items	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0
Pretax Income	71.5	17.0	3.8	65.3	82.1	22.3	22.0	77.3	78.5	14.1	16.6	58.5
+ Current Tax	18.3	5.4	-1.5	17.2	20.9	5.4	12.3	18.7	19.8	4.3	1.0	16.5
+ Deferred Tax	0.3	-0.7	-2.5	-0.8	-0.0	-0.5	-4.1	0.6	-0.1	-0.5	3.3	-1.6
Tax Expense	18.6	4.8	-4.0	16.4	20.8	4.9	8.1	19.3	19.7	3.8	4.4	14.9
+ Share of Associates & JVs	0.2	0.0	-0.1	0.2	0.2	0.0	0.0	0.2	0.4	0.2	-0.5	0.3
Net Income	53.2	12.3	7.8	49.0	61.5	17.4	13.9	58.1	59.1	10.5	11.7	43.9
+ Net Income — Continuing Ops	53.0	12.3	7.8	48.8	61.3	17.4	13.9	57.9	58.8	10.2	12.2	43.6
+ Other Comprehensive Income	-1.2	0.1	1.4	-1.7	1.9	-0.7	-0.7	-0.1	1.4	-1.5	2.4	-1.6
Total Comprehensive Income	51.9	12.4	9.1	47.3	63.3	16.6	13.1	58.1	60.5	9.0	14.1	42.3
Net Income to Common	—	12.3	7.8	49.0	61.5	—	—	58.1	59.1	10.5	11.7	43.9
Minority Interest	—	0.0	0.0	0.0	0.0	—	0.0	0.0	0.0	0.0	2.4	0.0
Per Share
Basic EPS	17.95	4.16	2.62	16.56	20.78	5.96	4.77	19.97	20.31	3.60	4.02	15.08
Diluted EPS	17.95	4.16	2.62	16.56	20.78	5.96	4.77	19.97	20.31	3.60	4.02	15.08
Other Comprehensive Income — detail
+ Other Comprehensive Income	—	—	—	—	—	—	-0.7	-0.1	1.4	-1.5	2.4	-1.6
+ Items NOT to be Reclassified to P&L	-1.2	0.1	1.4	-1.7	1.8	-0.7	-0.7	-0.1	1.4	-1.5	2.4	-2.1
+ Tax on Items NOT to be Reclassified	—	—	—	—	—	—	0.0	0.0	0.0	0.0	0.0	-0.5
+ Items to be Reclassified to P&L	—	—	—	-0.0	0.0	-0.0	0.0	-0.0	0.0	0.0	—	—
Comprehensive Income — Owners of Parent	—	12.3	—	—	—	16.6	—	58.1	—	9.0	14.1	42.3
Per Share — as-filed variants
Basic EPS — Continuing Operations	17.95	4.16	2.62	16.56	20.78	5.96	4.77	19.97	20.31	3.60	4.02	15.08
Diluted EPS — Continuing Operations	17.95	4.16	2.62	16.56	20.78	5.96	4.77	19.97	20.31	3.60	4.02	15.08
Derived — Gross Profit (Revenue − Materials − Purchases − Δ Inventories)
Gross Profit	173.5	108.0	86.9	180.6	198.5	129.2	131.4	201.7	219.7	124.8	128.9	193.2
Gross Margin %	24.93	30.16	31.88	27.50	31.65	36.12	36.60	29.18	34.45	32.43	30.23	31.59
Adjusted (ex-Exceptional Items) — derived
Pretax Income (Adjusted, as filed)	71.5	17.0	3.8	65.3	82.1	22.1	22.0	77.3	78.5	14.1	16.6	58.5
− Exceptional Items (reconciliation)	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0
Net Income Adj (tax-effected)	53.2	12.3	7.8	49.0	61.5	17.2	13.9	58.1	59.1	10.5	11.7	43.9
EPS Adj	17.95	4.16	2.62	16.56	20.78	5.90	4.77	19.97	20.31	3.60	4.02	15.08
Other Filed Concepts — mapped but not yet placed in the schedule
Face Value	10.00	10.00	10.00	10.00	10.00	10.00	—	10.00	10.00	10.00	10.00	10.00
Paid Up Equity Capital	29.6	29.6	29.6	29.6	29.6	29.1	29.1	29.1	29.1	29.1	29.1	29.1

As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: Q1 FY27 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.

Insecticides Q2 FY27 results date

Insecticides (NSE: INSECTICID) will announce its Q2 FY27 results (July–September 2026) on Thursday, 5 November 2026, according to the board-meeting notice it filed on 25 September 2026, which also lists a dividend. Its latest results are for Q1 FY27 (April–June 2026). Consolidated net profit was ₹43.9 crore, down 24.5% from ₹58.1 crore in Q1 FY26 and up 274.7% from ₹11.7 crore in Q4 FY26. Revenue from operations was ₹612 crore, down 11.5% year on year and up 43.5% from the previous quarter.

Board-meeting notice filed: 25 September 2026
Q2 FY26 results (a year earlier): 12 November 2025
Q1 FY27 results (the latest): 11 August 2026

Latest results: Q1 FY27 (Apr–Jun 2026) · consolidated

Q2 FY27 results date: 5 November 2026Thursday · notice filed 25 Sep
Q1 FY27 net profit: ₹43.9 Cr−24.5% vs Q1 FY26+274.7% vs Q4 FY26
Q1 FY27 revenue: ₹612 Cr−11.5% vs Q1 FY26+43.5% vs Q4 FY26
Q1 FY27 operating margin: 9.5%−1.7 pts vs Q1 FY26+5.7 pts vs Q4 FY26
Q2 FY26 net profit (a year earlier): ₹59.1 CrRevenue ₹638 Cr
Q1 FY27 EPS (basic): ₹15.08

Questions

When will Insecticides announce its Q2 FY27 results?

On 5 November 2026, the date of the board meeting called to approve them (notice filed with the exchanges on 25 September 2026). Last year it reported Q2 FY26 on 12 November 2025.

What will Insecticides' Q2 FY27 results be compared with?

With the same quarter a year earlier, Q2 FY26 (July–September 2025), when consolidated net profit was ₹59.1 crore and revenue from operations ₹638 crore. The latest quarter, Q1 FY27, had a net profit of ₹43.9 crore and revenue of ₹612 crore.

What were Insecticides' Q1 FY27 results?

Consolidated net profit was ₹43.9 crore, down 24.5% from ₹58.1 crore in Q1 FY26 and up 274.7% from ₹11.7 crore in Q4 FY26. Revenue from operations was ₹612 crore, down 11.5% year on year and up 43.5% from the previous quarter.

How has Insecticides' profit changed over the last four quarters?

Net profit by quarter: ₹59.1 crore in Q2 FY26, ₹10.5 crore in Q3 FY26, ₹11.7 crore in Q4 FY26 and ₹43.9 crore in Q1 FY27. That is ₹125 crore over the four quarters, down 17.0% from ₹151 crore in the four quarters before. Revenue from operations: ₹638 crore, ₹385 crore, ₹426 crore and ₹612 crore.

What was Insecticides' net profit in FY26?

Consolidated net profit was ₹139 crore in FY26 (April 2025–March 2026), down 1.8% from ₹142 crore in FY25. It was ₹102 crore in FY24 and ₹63.2 crore in FY23: up 120.5% over three years, 30.2% a year on average.

What was Insecticides' revenue in FY26?

Revenue from operations was ₹2,140 crore in FY26 (April 2025–March 2026), up 7.0% from ₹2,000 crore in FY25. It was ₹1,966 crore in FY24 and ₹1,801 crore in FY23: up 18.8% over three years, 5.9% a year on average.

Where do these Insecticides figures come from?

From Insecticides' own consolidated results filings to NSE, in ₹ crore as filed; the date from its board-meeting notices.

Consolidated figures from the company's filings to NSE. Every company's results dates this season are in the Q2 FY27 results calendar, part of Alpha Plus.